Global Antifungal Agents Market – Industry Analysis and Forecast (2019-2026) –By Drug Types, Therapeutic Indications, Types, Applications, and Region.

Global Antifungal Agents Market was valued at US$ 12.8 Bn in 2019 and is expected to reach US$ 17.6 Bn by 2026, at a CAGR of 4.06% during a forecast period. The report includes the analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region. To know about the Research Methodology:-Request Free Sample Report The antifungal agents are fungistatic in nature and are used to prevent and treat fungal infections such as candidiasis, ringworm, etc. Antifungal is basically the drugs which help in detecting and eliminating fungal pathogens from the foreign body with less toxic side effects to the body. The significant driver of increasing growth in the global antifungal agents market is the progress of drug resistance. The rising concern among the population regarding health issues has positively influenced the growth in the medical sector. The infections like yeasts and pathogenic fungi can occupy and overtake the human body. Therefore, there is an increasing demand for antifungal drugs in the market. Alternate treatment options and regulatory atmosphere are the major factors obstructing the growth of the antifungal agents market. Tropical drugs come in wide forms like pastes, ointments, powder, and others. Oral antifungal agents include fluconazole, terbinafine, itraconazole, and ketoconazole. Oral antifungal agents are kept for serious infection for which topical antifungal agents are ineffective or inappropriate. Oral antifungal agents are medicines, which are available only through prescription and dosage forms like capsules, suspensions, and tablets. Aspergillosis therapeutic indication is leading the market. Aspergillosis contains allergic reactions, lung infections, and infections in other organs. The common cases occur in people with underlying illnesses such as tuberculosis or chronic obstructive pulmonary disease, but with otherwise healthy immune systems. North America is expected to hold the largest share during the forecast period owing to the huge investments made in drug productions along with government initiatives related to fungal infections and their treatment. Asia-Pacific is projected to be the fastest-growing region for the antifungal agents market owing to the growing healthcare industry is boosting the antifungal agents market. China is expected to register major market growth in antifungal drugs owing to the rising access of the public with healthcare professionals and the growing economy. The report covers a comprehensive study of major market drivers, restraints, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.

The Scope of the Global Antifungal Agents Market: Inquire before buying

Global Antifungal Agents Market, by Drug Types:

• Systemic Azoles & Polyenes • Topical Azoles & Polyenes • Systemic Echinocandins & Antimetabolics • Other Drugs Types

Global Antifungal Agents Market, by Therapeutic Indications:

• Aspergillosis Therapeutic Indications • Dermatophytosis Therapeutic Indications • Candidiasis Therapeutic Indications • Others Therapeutic Indications

Global Antifungal Agents Market, by Types:

• Prescription • Over the counter (OTC)

Global Antifungal Agents Market, by Applications:

• Topical Antifungal Agents Applications • Oral Drugs Applications

Global Antifungal Agents Market, by Region:

• North America • Europe • Asia-Pacific • South America • Middle East & Africa

Key Player Operating in the Global Antifungal Agents Market:

• Abbott Laboratories, Inc. • Amplyx Pharmaceuticals, Inc. • Astellas Pharma, Inc. • Basilea Pharmaceutica AG • Bayer Healthcare LLC • Bristol-Myers Squibb Pharmaceuticals, Ltd. • Cosmo Pharmaceuticals NV • Gilead Sciences, Inc. • Janssen Pharmaceutica NV • Mayne Pharma, Inc. • Merck & Co., Inc. • Mylan Pharmaceuticals, Inc. • Nouvasant Pharmhealth Ltd. • Pfizer, Inc. • Sanofi-Aventis U.S. LLC • Scynexis, Inc. • Sumitomo Dainippon Pharma Co., Ltd. • Sun Pharmaceutical Industries, Ltd. • Teva Pharmaceutical Industries, Ltd. • Zydus Cadila Healthcare Ltd.

Global antifungal agents market

1. Preface 1.1. Research Objectives 1.2. Report Scope and Market Segmentation 2. Assumptions and Research Methodology 2.1. Abbreviations 3. Executive Summary 3.1. Global Antifungal Agents Market Size, by Market Value (US$ Bn) and Market 4. Market Overview 4.1. Introduction 4.2. Market Dynamics 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 4.3.7 Key Trends in Global Antifungal Agents Market 5. Global Antifungal Agents Market Analysis and Forecast 5.1. Global Antifungal Agents Market Size& Y-o-Y Growth Analysis 5.1.1. North America 5.1.2. Europe 5.1.3. Asia Pacific 5.1.4. Middle East & Africa 5.1.5. South America 6. Global Antifungal Agents Market Analysis and Forecast, By Drug Types 6.1. Introduction and Definition 6.2. Global Antifungal Agents Market Value Share Analysis, By Drug Types 6.3. Global Antifungal Agents Market Size (US$ Bn) Forecast, By Drug Types 6.4. Global Antifungal Agents Market Analysis, By Drug Types 6.5. Global Antifungal Agents Market Attractiveness Analysis, By Drug Types 6.6. Key Trends 6.6.1. Key Developments 7. Global Antifungal Agents Market Analysis and Forecast, By Therapeutic Indications 7.1. Introduction and Definition 7.2. Global Antifungal Agents Market Value Share Analysis, By Therapeutic Indications 7.3. Global Antifungal Agents Market Size (US$ Bn) Forecast, By Therapeutic Indications 7.4. Global Antifungal Agents Market Analysis, By Therapeutic Indications 7.5. Global Antifungal Agents Market Attractiveness Analysis, By Therapeutic Indications 7.6. Key Trends 7.6.1. Key Developments 8. Global Antifungal Agents Market Analysis and Forecast, By Types 8.1. Introduction and Definition 8.2. Global Antifungal Agents Market Value Share Analysis, By Types 8.3. Global Antifungal Agents Market Size (US$ Bn) Forecast, By Types 8.4. Global Antifungal Agents Market Analysis, By Types 8.5. Global Antifungal Agents Market Attractiveness Analysis, By Types 8.6. Key Trends 8.6.1. Key Developments 9. Global Antifungal Agents Market Analysis and Forecast, By Applications 9.1. Introduction and Definition 9.2. Global Antifungal Agents Market Value Share Analysis, By Applications 9.3. Global Antifungal Agents Market Size (US$ Bn) Forecast, By Applications 9.4. Global Antifungal Agents Market Analysis, By Applications 9.5. Global Antifungal Agents Market Attractiveness Analysis, By Applications 9.6. Key Trends 9.6.1. Key Developments 10. Global Antifungal Agents Market Analysis, by Region 10.1. Global Antifungal Agents Market Value Share Analysis, by Region 10.2. Global Antifungal Agents Market Size (US$ Bn) Forecast, by Region 10.3. Global Antifungal Agents Market Attractiveness Analysis, by Region 10.4. Key Trends 10.4.1. Key Developments 11. North America Antifungal Agents Market Analysis 11.1. Key Findings 11.2. North America Antifungal Agents Market Overview 11.3. North America Antifungal Agents Market Value Share Analysis, By Drug Types 11.4. North America Antifungal Agents Market Forecast, By Drug Types 11.4.1. Systemic Azoles & Polyenes 11.4.2. Topical Azoles & Polyenes 11.4.3. Systemic Echinocandins & Antimetabolics 11.4.4. Other Drugs Types 11.5. North America Antifungal Agents Market Value Share Analysis, By Therapeutic Indications 11.6. North America Antifungal Agents Market Forecast, By Therapeutic Indications 11.6.1. Aspergillosis Therapeutic Indications 11.6.2. Dermatophytosis Therapeutic Indications 11.6.3. Candidiasis Therapeutic Indications 11.6.4. Others Therapeutic Indications 11.7. North America Antifungal Agents Market Value Share Analysis, By Types 11.8. North America Antifungal Agents Market Forecast, By Types 11.8.1. Prescription 11.8.2. Over the counter (OTC) 11.9. North America Antifungal Agents Market Value Share Analysis, By Applications 11.10. North America Antifungal Agents Market Forecast, By Applications 11.10.1. Topical Antifungal Agents Applications 11.10.2. Oral Drugs Applications 11.11. North America Antifungal Agents Market Value Share Analysis, by Country 11.12. North America Antifungal Agents Market Forecast, by Country 11.12.1. U.S. 11.12.2. Canada 11.13. North America Antifungal Agents Market Analysis, by Country 11.14. U.S. Antifungal Agents Market Forecast, By Drug Types 11.14.1. Systemic Azoles & Polyenes 11.14.2. Topical Azoles & Polyenes 11.14.3. Systemic Echinocandins & Antimetabolics 11.14.4. Other Drugs Types 11.15. U.S. Antifungal Agents Market Forecast, By Therapeutic Indications 11.15.1. Aspergillosis Therapeutic Indications 11.15.2. Dermatophytosis Therapeutic Indications 11.15.3. Candidiasis Therapeutic Indications 11.15.4. Others Therapeutic Indications 11.16. U.S. Antifungal Agents Market Forecast, By Types 11.16.1. Prescription 11.16.2. Over the counter (OTC) 11.17. U.S. Antifungal Agents Market Forecast, By Applications 11.17.1. Topical Antifungal Agents Applications 11.17.2. Oral Drugs Applications 11.18. Canada Antifungal Agents Market Forecast, By Drug Types 11.18.1. Systemic Azoles & Polyenes 11.18.2. Topical Azoles & Polyenes 11.18.3. Systemic Echinocandins & Antimetabolics 11.18.4. Other Drugs Types 11.19. Canada Antifungal Agents Market Forecast, By Therapeutic Indications 11.19.1. Aspergillosis Therapeutic Indications 11.19.2. Dermatophytosis Therapeutic Indications 11.19.3. Candidiasis Therapeutic Indications 11.19.4. Others Therapeutic Indications 11.20. Canada Antifungal Agents Market Forecast, By Types 11.20.1. Prescription 11.20.2. Over the counter (OTC) 11.21. Canada Antifungal Agents Market Forecast, By Applications 11.21.1. Topical Antifungal Agents Applications 11.21.2. Oral Drugs Applications 11.22. North America Antifungal Agents Market Attractiveness Analysis 11.22.1. By Drug Types 11.22.2. By Therapeutic Indications 11.22.3. By Types 11.22.4. By Applications 11.23. PEST Analysis 11.24. Key Trends 11.24.1. Key Developments 12. Europe Antifungal Agents Market Analysis 12.1. Key Findings 12.2. Europe Antifungal Agents Market Overview 12.3. Europe Antifungal Agents Market Value Share Analysis, By Drug Types 12.4. Europe Antifungal Agents Market Forecast, By Drug Types 12.4.1. Systemic Azoles & Polyenes 12.4.2. Topical Azoles & Polyenes 12.4.3. Systemic Echinocandins & Antimetabolics 12.4.4. Other Drugs Types 12.5. Europe Antifungal Agents Market Value Share Analysis, By Therapeutic Indications 12.6. Europe Antifungal Agents Market Forecast, By Therapeutic Indications 12.6.1. Aspergillosis Therapeutic Indications 12.6.2. Dermatophytosis Therapeutic Indications 12.6.3. Candidiasis Therapeutic Indications 12.6.4. Others Therapeutic Indications 12.7. Europe Antifungal Agents Market Value Share Analysis, By Types 12.8. Europe Antifungal Agents Market Forecast, By Types 12.8.1. Prescription 12.8.2. Over the counter (OTC) 12.9. Europe Antifungal Agents Market Value Share Analysis, By Applications 12.10. Europe Antifungal Agents Market Forecast, By Applications 12.10.1. Topical Antifungal Agents Applications 12.10.2. Oral Drugs Applications 12.11. Europe Antifungal Agents Market Value Share Analysis, by Country 12.12. Europe Antifungal Agents Market Forecast, by Country 12.12.1. Germany 12.12.2. U.K. 12.12.3. France 12.12.4. Italy 12.12.5. Spain 12.12.6. Rest of Europe 12.13. Europe Antifungal Agents Market Analysis, by Country/ Sub-region 12.14. Germany Antifungal Agents Market Forecast, By Drug Types 12.14.1. Systemic Azoles & Polyenes 12.14.2. Topical Azoles & Polyenes 12.14.3. Systemic Echinocandins & Antimetabolics 12.14.4. Other Drugs Types 12.15. Germany Antifungal Agents Market Forecast, By Therapeutic Indications 12.15.1. Aspergillosis Therapeutic Indications 12.15.2. Dermatophytosis Therapeutic Indications 12.15.3. Candidiasis Therapeutic Indications 12.15.4. Others Therapeutic Indications 12.16. Germany Antifungal Agents Market Forecast, By Types 12.16.1. Prescription 12.16.2. Over the counter (OTC) 12.17. Germany Antifungal Agents Market Forecast, By Applications 12.17.1. Topical Antifungal Agents Applications 12.17.2. Oral Drugs Applications 12.18. U.K. Antifungal Agents Market Forecast, By Drug Types 12.18.1. Systemic Azoles & Polyenes 12.18.2. Topical Azoles & Polyenes 12.18.3. Systemic Echinocandins & Antimetabolics 12.18.4. Other Drugs Types 12.19. U.K. Antifungal Agents Market Forecast, By Therapeutic Indications 12.19.1. Aspergillosis Therapeutic Indications 12.19.2. Dermatophytosis Therapeutic Indications 12.19.3. Candidiasis Therapeutic Indications 12.19.4. Others Therapeutic Indications 12.20. U.K. Antifungal Agents Market Forecast, By Types 12.20.1. Prescription 12.20.2. Over the counter (OTC) 12.21. U.K. Antifungal Agents Market Forecast, By Applications 12.21.1. Topical Antifungal Agents Applications 12.21.2. Oral Drugs Applications 12.22. France Antifungal Agents Market Forecast, By Drug Types 12.22.1. Systemic Azoles & Polyenes 12.22.2. Topical Azoles & Polyenes 12.22.3. Systemic Echinocandins & Antimetabolics 12.22.4. Other Drugs Types 12.23. France Antifungal Agents Market Forecast, By Therapeutic Indications 12.23.1. Aspergillosis Therapeutic Indications 12.23.2. Dermatophytosis Therapeutic Indications 12.23.3. Candidiasis Therapeutic Indications 12.23.4. Others Therapeutic Indications 12.24. France Antifungal Agents Market Forecast, By Types 12.24.1. Prescription 12.24.2. Over the counter (OTC) 12.25. France Antifungal Agents Market Forecast, By Applications 12.25.1. Topical Antifungal Agents Applications 12.25.2. Oral Drugs Applications 12.26. Italy Antifungal Agents Market Forecast, By Drug Types 12.26.1. Systemic Azoles & Polyenes 12.26.2. Topical Azoles & Polyenes 12.26.3. Systemic Echinocandins & Antimetabolics 12.26.4. Other Drugs Types 12.27. Italy Antifungal Agents Market Forecast, By Therapeutic Indications 12.27.1. Aspergillosis Therapeutic Indications 12.27.2. Dermatophytosis Therapeutic Indications 12.27.3. Candidiasis Therapeutic Indications 12.27.4. Others Therapeutic Indications 12.28. Italy Antifungal Agents Market Forecast, By Types 12.28.1. Prescription 12.28.2. Over the counter (OTC) 12.29. Italy Antifungal Agents Market Forecast, By Applications 12.29.1. Topical Antifungal Agents Applications 12.29.2. Oral Drugs Applications 12.30. Spain Antifungal Agents Market Forecast, By Drug Types 12.30.1. Systemic Azoles & Polyenes 12.30.2. Topical Azoles & Polyenes 12.30.3. Systemic Echinocandins & Antimetabolics 12.30.4. Other Drugs Types 12.31. Spain Antifungal Agents Market Forecast, By Therapeutic Indications 12.31.1. Aspergillosis Therapeutic Indications 12.31.2. Dermatophytosis Therapeutic Indications 12.31.3. Candidiasis Therapeutic Indications 12.31.4. Others Therapeutic Indications 12.32. Spain Antifungal Agents Market Forecast, By Types 12.32.1. Prescription 12.32.2. Over the counter (OTC) 12.33. Spain Antifungal Agents Market Forecast, By Applications 12.33.1. Topical Antifungal Agents Applications 12.33.2. Oral Drugs Applications 12.34. Rest of Europe Antifungal Agents Market Forecast, By Drug Types 12.34.1. Systemic Azoles & Polyenes 12.34.2. Topical Azoles & Polyenes 12.34.3. Systemic Echinocandins & Antimetabolics 12.34.4. Other Drugs Types 12.35. Rest of Europe Antifungal Agents Market Forecast, By Therapeutic Indications 12.35.1. Aspergillosis Therapeutic Indications 12.35.2. Dermatophytosis Therapeutic Indications 12.35.3. Candidiasis Therapeutic Indications 12.35.4. Others Therapeutic Indications 12.36. Rest of Europe Antifungal Agents Market Forecast, By Types 12.36.1. Prescription 12.36.2. Over the counter (OTC) 12.37. Rest Of Europe Antifungal Agents Market Forecast, By Applications 12.37.1. Topical Antifungal Agents Applications 12.37.2. Oral Drugs Applications 12.38. Europe Antifungal Agents Market Attractiveness Analysis 12.38.1. By Drug Types 12.38.2. By Therapeutic Indications 12.38.3. By Types 12.38.4. By Applications 12.39. PEST Analysis 12.40. Key Trends 12.40.1. Key Developments 13. Asia Pacific Antifungal Agents Market Analysis 13.1. Key Findings 13.2. Asia Pacific Antifungal Agents Market Overview 13.3. Asia Pacific Antifungal Agents Market Value Share Analysis, By Drug Types 13.4. Asia Pacific Antifungal Agents Market Forecast, By Drug Types 13.4.1. Systemic Azoles & Polyenes 13.4.2. Topical Azoles & Polyenes 13.4.3. Systemic Echinocandins & Antimetabolics 13.4.4. Other Drugs Types 13.5. Asia Pacific Antifungal Agents Market Value Share Analysis, By Therapeutic Indications 13.6. Asia Pacific Antifungal Agents Market Forecast, By Therapeutic Indications 13.6.1. Aspergillosis Therapeutic Indications 13.6.2. Dermatophytosis Therapeutic Indications 13.6.3. Candidiasis Therapeutic Indications 13.6.4. Others Therapeutic Indications 13.7. Asia Pacific Antifungal Agents Market Value Share Analysis, By Types 13.8. Asia Pacific Antifungal Agents Market Forecast, By Types 13.8.1. Prescription 13.8.2. Over the counter (OTC) 13.9. Asia Pacific Antifungal Agents Market Value Share Analysis, By Applications 13.10. Asia Pacific Antifungal Agents Market Forecast, By Applications 13.10.1. Topical Antifungal Agents Applications 13.10.2. Oral Drugs Applications 13.11. Asia Pacific Antifungal Agents Market Value Share Analysis, by Country 13.12. Asia Pacific Antifungal Agents Market Forecast, by Country 13.12.1. China 13.12.2. India 13.12.3. Japan 13.12.4. ASEAN 13.12.5. Rest of Asia Pacific 13.13. Asia Pacific Antifungal Agents Market Analysis, by Country/ Sub-region 13.14. China Antifungal Agents Market Forecast, By Drug Types 13.14.1. Systemic Azoles & Polyenes 13.14.2. Topical Azoles & Polyenes 13.14.3. Systemic Echinocandins & Antimetabolics 13.14.4. Other Drugs Types 13.15. China Antifungal Agents Market Forecast, By Therapeutic Indications 13.15.1. Aspergillosis Therapeutic Indications 13.15.2. Dermatophytosis Therapeutic Indications 13.15.3. Candidiasis Therapeutic Indications 13.15.4. Others Therapeutic Indications 13.16. China Antifungal Agents Market Forecast, By Types 13.16.1. Prescription 13.16.2. Over the counter (OTC) 13.17. China Antifungal Agents Market Forecast, By Applications 13.17.1. Topical Antifungal Agents Applications 13.17.2. Oral Drugs Applications 13.18. India Antifungal Agents Market Forecast, By Drug Types 13.18.1. Systemic Azoles & Polyenes 13.18.2. Topical Azoles & Polyenes 13.18.3. Systemic Echinocandins & Antimetabolics 13.18.4. Other Drugs Types 13.19. India Antifungal Agents Market Forecast, By Therapeutic Indications 13.19.1. Aspergillosis Therapeutic Indications 13.19.2. Dermatophytosis Therapeutic Indications 13.19.3. Candidiasis Therapeutic Indications 13.19.4. Others Therapeutic Indications 13.20. India Antifungal Agents Market Forecast, By Types 13.20.1. Prescription 13.20.2. Over the counter (OTC) 13.21. India Antifungal Agents Market Forecast, By Applications 13.21.1. Topical Antifungal Agents Applications 13.21.2. Oral Drugs Applications 13.22. Japan Antifungal Agents Market Forecast, By Drug Types 13.22.1. Systemic Azoles & Polyenes 13.22.2. Topical Azoles & Polyenes 13.22.3. Systemic Echinocandins & Antimetabolics 13.22.4. Other Drugs Types 13.23. Japan Antifungal Agents Market Forecast, By Therapeutic Indications 13.23.1. Aspergillosis Therapeutic Indications 13.23.2. Dermatophytosis Therapeutic Indications 13.23.3. Candidiasis Therapeutic Indications 13.23.4. Others Therapeutic Indications 13.24. Japan Antifungal Agents Market Forecast, By Types 13.24.1. Prescription 13.24.2. Over the counter (OTC) 13.25. Japan Antifungal Agents Market Forecast, By Applications 13.25.1. Topical Antifungal Agents Applications 13.25.2. Oral Drugs Applications 13.26. ASEAN Antifungal Agents Market Forecast, By Drug Types 13.26.1. Systemic Azoles & Polyenes 13.26.2. Topical Azoles & Polyenes 13.26.3. Systemic Echinocandins & Antimetabolics 13.26.4. Other Drugs Types 13.27. ASEAN Antifungal Agents Market Forecast, By Therapeutic Indications 13.27.1. Aspergillosis Therapeutic Indications 13.27.2. Dermatophytosis Therapeutic Indications 13.27.3. Candidiasis Therapeutic Indications 13.27.4. Others Therapeutic Indications 13.28. ASEAN Antifungal Agents Market Forecast, By Types 13.28.1. Prescription 13.28.2. Over the counter (OTC) 13.29. ASEAN Antifungal Agents Market Forecast, By Applications 13.29.1. Topical Antifungal Agents Applications 13.29.2. Oral Drugs Applications 13.30. Rest of Asia Pacific Antifungal Agents Market Forecast, By Drug Types 13.30.1. Systemic Azoles & Polyenes 13.30.2. Topical Azoles & Polyenes 13.30.3. Systemic Echinocandins & Antimetabolics 13.30.4. Other Drugs Types 13.31. Rest of Asia Pacific Antifungal Agents Market Forecast, By Therapeutic Indications 13.31.1. Aspergillosis Therapeutic Indications 13.31.2. Dermatophytosis Therapeutic Indications 13.31.3. Candidiasis Therapeutic Indications 13.31.4. Others Therapeutic Indications 13.32. Rest of Asia Pacific Antifungal Agents Market Forecast, By Types 13.32.1. Prescription 13.32.2. Over the counter (OTC) 13.33. Rest of Asia Pacific Antifungal Agents Market Forecast, By Applications 13.33.1. Topical Antifungal Agents Applications 13.33.2. Oral Drugs Applications 13.34. Asia Pacific Antifungal Agents Market Attractiveness Analysis 13.34.1. By Drug Types 13.34.2. By Therapeutic Indications 13.34.3. By Types 13.34.4. By Applications 13.35. PEST Analysis 13.36. Key Trends 13.36.1. Key Developments 14. Middle East & Africa Antifungal Agents Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Antifungal Agents Market Overview 14.3. Middle East & Africa Antifungal Agents Market Value Share Analysis, By Drug Types 14.4. Middle East & Africa Antifungal Agents Market Forecast, By Drug Types 14.4.1. Systemic Azoles & Polyenes 14.4.2. Topical Azoles & Polyenes 14.4.3. Systemic Echinocandins & Antimetabolics 14.4.4. Other Drugs Types 14.5. Middle East & Africa Antifungal Agents Market Value Share Analysis, By Therapeutic Indications 14.6. Middle East & Africa Antifungal Agents Market Forecast, By Therapeutic Indications 14.6.1. Aspergillosis Therapeutic Indications 14.6.2. Dermatophytosis Therapeutic Indications 14.6.3. Candidiasis Therapeutic Indications 14.6.4. Others Therapeutic Indications 14.7. Middle East & Africa Antifungal Agents Market Value Share Analysis, By Types 14.8. Middle East & Africa Antifungal Agents Market Forecast, By Types 14.8.1. Prescription 14.8.2. Over the counter (OTC) 14.9. Middle East & Africa Antifungal Agents Market Value Share Analysis, By Applications 14.10. Middle East & Africa Antifungal Agents Market Forecast, By Applications 14.10.1. Topical Antifungal Agents Applications 14.10.2. Oral Drugs Applications 14.11. Middle East & Africa Antifungal Agents Market Value Share Analysis, by Country 14.12. Middle East & Africa Antifungal Agents Market Forecast, by Country 14.12.1. GCC 14.12.2. South Africa 14.12.3. Rest of Middle East & Africa 14.13. Middle East & Africa Antifungal Agents Market Analysis, by Country/ Sub-region 14.14. GCC Antifungal Agents Market Forecast, By Drug Types 14.14.1. Systemic Azoles & Polyenes 14.14.2. Topical Azoles & Polyenes 14.14.3. Systemic Echinocandins & Antimetabolics 14.14.4. Other Drugs Types 14.15. GCC Antifungal Agents Market Forecast, By Therapeutic Indications 14.15.1. Aspergillosis Therapeutic Indications 14.15.2. Dermatophytosis Therapeutic Indications 14.15.3. Candidiasis Therapeutic Indications 14.15.4. Others Therapeutic Indications 14.16. GCC Antifungal Agents Market Forecast, By Types 14.16.1. Prescription 14.16.2. Over the counter (OTC) 14.17. GCC Antifungal Agents Market Forecast, By Applications 14.18. Topical Antifungal Agents Applications 14.19. Oral Drugs Applications 14.20. Others South Africa Antifungal Agents Market Forecast, By Drug Types 14.20.1. Systemic Azoles & Polyenes 14.20.2. Topical Azoles & Polyenes 14.20.3. Systemic Echinocandins & Antimetabolics 14.20.4. Other Drugs Types 14.21. South Africa Antifungal Agents Market Forecast, By Therapeutic Indications 14.21.1. Aspergillosis Therapeutic Indications 14.21.2. Dermatophytosis Therapeutic Indications 14.21.3. Candidiasis Therapeutic Indications 14.21.4. Others Therapeutic Indications 14.22. South Africa Antifungal Agents Market Forecast, By Types 14.22.1. Prescription 14.22.2. Over the counter (OTC) 14.23. South Africa Antifungal Agents Market Forecast, By Applications 14.23.1. Topical Antifungal Agents Applications 14.23.2. Oral Drugs Applications 14.24. Rest of Middle East & Africa Antifungal Agents Market Forecast, By Drug Types 14.24.1. Systemic Azoles & Polyenes 14.24.2. Topical Azoles & Polyenes 14.24.3. Systemic Echinocandins & Antimetabolics 14.24.4. Other Drugs Types 14.25. Rest of Middle East & Africa Antifungal Agents Market Forecast, By Therapeutic Indications 14.25.1. Aspergillosis Therapeutic Indications 14.25.2. Dermatophytosis Therapeutic Indications 14.25.3. Candidiasis Therapeutic Indications 14.25.4. Others Therapeutic Indications 14.26. Rest of Middle East & Africa Antifungal Agents Market Forecast, By Types 14.26.1. Prescription 14.26.2. Over the counter (OTC) 14.27. Rest of Middle East & Africa Antifungal Agents Market Forecast, By Applications 14.27.1. Topical Antifungal Agents Applications 14.27.2. Oral Drugs Applications 14.28. Middle East & Africa Antifungal Agents Market Attractiveness Analysis 14.28.1. By Drug Types 14.28.2. By Therapeutic Indications 14.28.3. By Types 14.28.4. By Applications 14.29. PEST Analysis 14.30. Key Trends 14.30.1. Key Developments 15. South America Antifungal Agents Market Analysis 15.1. Key Findings 15.2. South America Antifungal Agents Market Overview 15.3. South America Antifungal Agents Market Value Share Analysis, By Drug Types 15.4. South America Antifungal Agents Market Forecast, By Drug Types 15.4.1. Systemic Azoles & Polyenes 15.4.2. Topical Azoles & Polyenes 15.4.3. Systemic Echinocandins & Antimetabolics 15.4.4. Other Drugs Types 15.5. South America Antifungal Agents Market Value Share Analysis, By Therapeutic Indications 15.6. South America Antifungal Agents Market Forecast, By Therapeutic Indications 15.6.1. Aspergillosis Therapeutic Indications 15.6.2. Dermatophytosis Therapeutic Indications 15.6.3. Candidiasis Therapeutic Indications 15.6.4. Others Therapeutic Indications 15.7. South America Antifungal Agents Market Value Share Analysis, By Types 15.8. South America Antifungal Agents Market Forecast, By Types 15.8.1. Prescription 15.8.2. Over the counter (OTC) 15.9. South America Antifungal Agents Market Value Share Analysis, By Applications 15.10. South America Antifungal Agents Market Forecast, By Applications 15.10.1. Topical Antifungal Agents Applications 15.10.2. Oral Drugs Applications 15.11. South America Antifungal Agents Market Value Share Analysis, by Country 15.12. South America Antifungal Agents Market Forecast, by Country 15.12.1. Brazil 15.12.2. Mexico 15.12.3. Rest of South America 15.13. South America Antifungal Agents Market Analysis, by Country/ Sub-region 15.14. Brazil Antifungal Agents Market Forecast, By Drug Types 15.14.1. Systemic Azoles & Polyenes 15.14.2. Topical Azoles & Polyenes 15.14.3. Systemic Echinocandins & Antimetabolics 15.14.4. Other Drugs Types 15.15. Brazil Antifungal Agents Market Forecast, By Therapeutic Indications 15.15.1. Aspergillosis Therapeutic Indications 15.15.2. Dermatophytosis Therapeutic Indications 15.15.3. Candidiasis Therapeutic Indications 15.15.4. Others Therapeutic Indications 15.16. Brazil Antifungal Agents Market Forecast, By Types 15.16.1. Prescription 15.16.2. Over the counter (OTC) 15.17. Brazil Antifungal Agents Market Forecast, By Applications 15.17.1. Topical Antifungal Agents Applications 15.17.2. Oral Drugs Applications 15.18. Mexico Antifungal Agents Market Forecast, By Drug Types 15.18.1. Systemic Azoles & Polyenes 15.18.2. Topical Azoles & Polyenes 15.18.3. Systemic Echinocandins & Antimetabolics 15.18.4. Other Drugs Types 15.19. Mexico Antifungal Agents Market Forecast, By Therapeutic Indications 15.19.1. Aspergillosis Therapeutic Indications 15.19.2. Dermatophytosis Therapeutic Indications 15.19.3. Candidiasis Therapeutic Indications 15.19.4. Others Therapeutic Indications 15.20. Mexico Antifungal Agents Market Forecast, By Types 15.20.1. Prescription 15.20.2. Over the counter (OTC) 15.21. Mexico Antifungal Agents Market Forecast, By Applications 15.21.1. Topical Antifungal Agents Applications 15.21.2. Oral Drugs Applications 15.22. Rest of South America Antifungal Agents Market Forecast, By Drug Types 15.22.1. Systemic Azoles & Polyenes 15.22.2. Topical Azoles & Polyenes 15.22.3. Systemic Echinocandins & Antimetabolics 15.22.4. Other Drugs Types 15.23. Rest of South America Antifungal Agents Market Forecast, By Therapeutic Indications 15.23.1. Aspergillosis Therapeutic Indications 15.23.2. Dermatophytosis Therapeutic Indications 15.23.3. Candidiasis Therapeutic Indications 15.23.4. Others Therapeutic Indications 15.24. Rest of South America Antifungal Agents Market Forecast, By Types 15.24.1. Prescription 15.24.2. Over the counter (OTC) 15.25. Rest of South America Antifungal Agents Market Forecast, By Applications 15.25.1. Topical Antifungal Agents Applications 15.25.2. Oral Drugs Applications 15.26. South America Antifungal Agents Market Attractiveness Analysis 15.26.1. By Drug Types 15.26.2. By Therapeutic Indications 15.26.3. By Types 15.26.4. By Applications 15.27. PEST Analysis 15.28. Key Trends 15.28.1. Key Developments 16. Company Landscape 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.3. Competitive Benchmarking of Company and Services 16.4. Company Profiles: Key Players 16.4.1. Zydus Cadila Healthcare Ltd. 16.4.1.1. Company Overview 16.4.1.2. Financial Overview 16.4.1.3. Business Strategy 16.4.1.4. Recent Developments 16.4.1.5. Development Footprint 16.4.2. Abbott Laboratories, Inc. 16.4.3. Amplyx Pharmaceuticals, Inc. 16.4.4. Astellas Pharma, Inc. 16.4.5. Basilea Pharmaceutica AG 16.4.6. Bayer Healthcare LLC 16.4.7. Bristol-Myers Squibb Pharmaceuticals, Ltd. 16.4.8. Cosmo Pharmaceuticals NV 16.4.9. Gilead Sciences, Inc. 16.4.10. Janssen Pharmaceutica NV 16.4.11. Mayne Pharma, Inc. 16.4.12. Merck & Co., Inc. 16.4.13. Mylan Pharmaceuticals, Inc. 16.4.14. Nouvasant Pharmhealth Ltd. 16.4.15. Pfizer, Inc. 16.4.16. Sanofi-Aventis U.S. LLC 16.4.17. Scynexis, Inc. 16.4.18. Sumitomo Dainippon Pharma Co., Ltd. 16.4.19. Sun Pharmaceutical Industries, Ltd. 16.4.20. Teva Pharmaceutical Industries, Ltd. 17. Primary Key Insights

About This Report

Report ID23804
Category Healthcare
Published DateJan 2019
Updated DateOct 2020
Contact Us